Covalent coupling of Spike’s receptor binding domain to a multimeric carrier produces a high immune response against SARS-CoV-2

The receptor binding domain (RBD) of the Spike protein from SARS-CoV-2 is a promising candidate to develop effective COVID-19 vaccines since it can induce potent neutralizing antibodies. We have previously reported the highly efficient production of RBD in Pichia pastoris, which is structurally simi...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8758758/
https://www.ncbi.nlm.nih.gov/pubmed/35027583
http://dx.doi.org/10.1038/s41598-021-03675-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8758758/
https://www.ncbi.nlm.nih.gov/pubmed/35027583
http://dx.doi.org/10.1038/s41598-021-03675-0

Ejemplares similares